IN2012DN01414A - - Google Patents

Download PDF

Info

Publication number
IN2012DN01414A
IN2012DN01414A IN1414DEN2012A IN2012DN01414A IN 2012DN01414 A IN2012DN01414 A IN 2012DN01414A IN 1414DEN2012 A IN1414DEN2012 A IN 1414DEN2012A IN 2012DN01414 A IN2012DN01414 A IN 2012DN01414A
Authority
IN
India
Prior art keywords
nitroimidazooxazines
drugs
alone
novel
preparation
Prior art date
Application number
Inventor
William Alexander Denny
Andrew M Thompson
Adrian Blaser
Zhenkun Ma
Brian Desmond Palmer
Hamish Scott Sutherland
Iveta Kmentova
Original Assignee
Global Alliance For Tb Drug Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Global Alliance For Tb Drug Dev filed Critical Global Alliance For Tb Drug Dev
Publication of IN2012DN01414A publication Critical patent/IN2012DN01414A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with heterocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

The present invention relates to novel nitroimidazooxazines, to their preparation, and to their use as drugs for treating Mycobacterium tuberculosis and other microbial infections, either alone or in combination with other anti-infective treatments.
IN1414DEN2012 2009-07-31 2010-07-30 IN2012DN01414A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23039609P 2009-07-31 2009-07-31
PCT/US2010/043906 WO2011014774A1 (en) 2009-07-31 2010-07-30 Nitroimidazooxazines and their uses in anti-tubercular therapy

Publications (1)

Publication Number Publication Date
IN2012DN01414A true IN2012DN01414A (en) 2015-06-05

Family

ID=42937154

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1414DEN2012 IN2012DN01414A (en) 2009-07-31 2010-07-30

Country Status (12)

Country Link
EP (1) EP2459571B1 (en)
JP (1) JP5781072B2 (en)
KR (1) KR101746482B1 (en)
CN (1) CN102753558B (en)
AU (1) AU2010278777B2 (en)
BR (1) BR112012002278A2 (en)
CA (1) CA2769359C (en)
ES (1) ES2536997T3 (en)
IN (1) IN2012DN01414A (en)
NZ (1) NZ598121A (en)
RU (1) RU2542988C2 (en)
WO (1) WO2011014774A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012141338A1 (en) * 2011-04-15 2012-10-18 Otsuka Pharmaceutical Co., Ltd. 6,7 - dihydroimidazo [2, 1 - b] [1, 3] oxazine bactericides
CN104059082B (en) * 2013-03-21 2016-08-03 苏州迈泰生物技术有限公司 Nitroimidazole heterocycle compound and the application in preparation treatment tubercular drugs thereof
KR101682356B1 (en) 2014-11-04 2016-12-06 한국화학연구원 Imidazo oxazine derivatives, pharmaceutically acceptable salts thereof or optical isomer thereof and pharmaceutical composition containing the same as an active ingredient
WO2016119706A1 (en) 2015-01-29 2016-08-04 南京明德新药研发股份有限公司 Anti-pulmonary tuberculosis nitroimidazole derivative
CN108047248A (en) * 2018-02-12 2018-05-18 丹诺医药(苏州）有限公司 The application of oxazolidone-nitro glyoxaline coupling molecule
CN113527331A (en) * 2020-04-17 2021-10-22 南京长澳医药科技有限公司 Nitroimidazole derivative and preparation method and application thereof
CN113355439A (en) * 2021-06-07 2021-09-07 深圳市普瑞康生物技术有限公司 Novel combined detection method for latent infection and morbidity of mycobacterium tuberculosis
CN114469946B (en) * 2022-02-24 2023-10-24 首都医科大学附属北京胸科医院 Use of delamanib as CXCL10 inhibitor

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09509963A (en) 1994-03-08 1997-10-07 アメリカン・ホーム・プロダクツ・コーポレイション Thiazolidinedione derivatives as anti-hyperglycemic agents
US6087358A (en) * 1995-06-26 2000-07-11 Pathogenesis Corporation Nitro-[2,1-b]imidazopyran compounds and antibacterial uses thereof
US5668127A (en) 1995-06-26 1997-09-16 Pathogenesis Corporation Nitroimidazole antibacterial compounds and methods of use thereof
TWI347946B (en) * 2002-10-11 2011-09-01 Otsuka Pharma Co Ltd 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound
CN100497345C (en) * 2003-10-31 2009-06-10 大塚制药株式会社 2, 3-dihydro-6-nitroimidazolo [2,1-b] oxazole compounds for the treatment of tuberculosis
DE602005004040T2 (en) 2004-01-16 2008-12-11 Sumitomo Chemical Co., Ltd. Malononitrile compounds as pesticides
TWI300409B (en) * 2004-02-18 2008-09-01 Otsuka Pharma Co Ltd Method for producing 4-nitroimidazole compound
WO2006043121A1 (en) * 2004-10-20 2006-04-27 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
ATE529430T1 (en) * 2005-07-28 2011-11-15 Vertex Pharma CASPASE INHIBITOR PROPHARMACIES
US20080275035A1 (en) * 2005-12-23 2008-11-06 Jan Jiricek Nitroimidazole Compounds
JP5613656B2 (en) * 2008-03-26 2014-10-29 グローバル、アライアンス、フォア、ティービー、ドラッグ、ディベロップメント Bicyclic nitroimidazoles covalently linked to substituted phenyloxazolidinones

Also Published As

Publication number Publication date
BR112012002278A2 (en) 2020-09-15
RU2012107176A (en) 2013-09-10
JP5781072B2 (en) 2015-09-16
KR20120084713A (en) 2012-07-30
ES2536997T3 (en) 2015-06-01
EP2459571B1 (en) 2015-03-11
AU2010278777A1 (en) 2012-03-01
CN102753558A (en) 2012-10-24
KR101746482B1 (en) 2017-06-27
NZ598121A (en) 2013-04-26
EP2459571A1 (en) 2012-06-06
CA2769359C (en) 2017-03-07
AU2010278777B2 (en) 2015-05-07
WO2011014774A1 (en) 2011-02-03
JP2013500996A (en) 2013-01-10
CA2769359A1 (en) 2011-02-03
CN102753558B (en) 2014-10-15
RU2542988C2 (en) 2015-02-27

Similar Documents

Publication Publication Date Title
MX2012010671A (en) Anti-infective compounds.
IN2012DN01414A (en)
MX2019009132A (en) Synergistic bacterial compositions and methods of production and use thereof.
EA033311B1 (en) Benzoxaborole derivatives as antibacterial agents
PH12016502092A1 (en) Antimicrobial compounds and methods of making and using the same
PH12016500207A1 (en) Anti-infective compounds
WO2010090860A3 (en) Methods and compositions for treating bacterial infection
MX349827B (en) Nitrogen containing compounds and their use.
EP2730576A3 (en) Anti-infective compounds
PL2748165T3 (en) 1,6-diazabicyclo[3,2,1]octan-7-one derivatives and their use in the treatment of bacterial infections.
EP2536406A4 (en) Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses
WO2009140309A3 (en) Boron-containing small molecules
EP3409666A3 (en) Seca inhibitors and methods of making and using thereof
ZA201307963B (en) 1,6- diazabicyclo [3,2,1] octan-7 one derivatives and their use in the treatment of bacterial infections
MX368346B (en) 1,6- diazabicyclo [3,2,1] octan- 7- one derivatives and their use in the treatment of bacterial infections.
WO2012003474A3 (en) Compositions and methods related to protein a (spa) variants
MX2012001156A (en) Trisubstituted boron-containing molecules.
MY176900A (en) Antimicrobial compounds and methods of making and using the same
MX363678B (en) Combination therapy comprising oxazolidinone-quinolones for use in treating bacterial infections.
PH12015502375A1 (en) Antimicrobial compounds and methods of making and using the same
MX342226B (en) Use of streptococcus salivarius in the treatment of chronic infections of the respiratory tract.
WO2013166282A3 (en) Methods and compositions for treating bacterial infection
MY161870A (en) Antimicrobial compounds and methods of making and using the same
MX360411B (en) Use of thiosulphate in order to potentiate the anti-pathogen effect of lactobacillus.
PH12014501239A1 (en) Thymol and totarol antibacterial composition